Showing results (121-130 of 184) with videos related to
Sort By:
Pageof 19
Open Forum Infectious Diseases|August 29, 2020
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)Maroussia Roelens, Barbara Bertisch, Darius Moradpour, et al.Hepatology (Baltimore, Md.)|December 11, 2023
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis EAli Saadat, Jérôme Gouttenoire, Paolo Ripellino, et al.Journal of Hepatology|December 3, 2014
Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavageChristoph Welsch, Katrin Haselow, Jérôme Gouttenoire, et al.Swiss Medical Weekly|August 8, 2012
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinomaLorenz Kuske, Armand Mensen, Beat Müllhaupt, et al.Journal of Thrombosis and Haemostasis : JTH|March 23, 2025
Effect of direct oral anticoagulants in cirrhosis: an in vitro studyCindy Pereira Portela, Debora Bertaggia Calderara, Elise Mdawar-Bailly, et al.Journal of Hepatology|January 18, 2011
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosisTao Cai, Jean-François Dufour, Beat Muellhaupt, et al.Journal of Virology|October 23, 2009
Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptationMaria Ripoli, Annamaria D'Aprile, Giovanni Quarato, et al.Hepatology (Baltimore, Md.)|January 2, 2010
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemPantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, et al.Plos One|July 23, 2020
OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A proteaseHuong T L Tran, Kenichi Morikawa, Anggakusuma, et al.Journal for Immunotherapy of Cancer|October 25, 2022
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse eventsAlexander Coukos, Julien Vionnet, Michel Obeid, et al.Pageof 19